Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

262 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relative stability of meningococcal serogroup A and X polysaccharides.
Berti F, Romano MR, Micoli F, Pinto V, Cappelletti E, Gavini M, Proietti D, Pluschke G, MacLennan CA, Costantino P. Berti F, et al. Among authors: pluschke g. Vaccine. 2012 Oct 5;30(45):6409-15. doi: 10.1016/j.vaccine.2012.08.021. Epub 2012 Aug 22. Vaccine. 2012. PMID: 22921741
Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.
Micoli F, Romano MR, Tontini M, Cappelletti E, Gavini M, Proietti D, Rondini S, Swennen E, Santini L, Filippini S, Balocchi C, Adamo R, Pluschke G, Norheim G, Pollard A, Saul A, Rappuoli R, MacLennan CA, Berti F, Costantino P. Micoli F, et al. Among authors: pluschke g. Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):19077-82. doi: 10.1073/pnas.1314476110. Epub 2013 Nov 4. Proc Natl Acad Sci U S A. 2013. PMID: 24191022 Free PMC article.
Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.
Dakar discussion group on priorities for research on epidemic meningococcal disease in Africa; Altmann D, Aseffa A, Bash M, Basta N, Borrow R, Broome C, Caugant D, Clark T, Collard JM, Djingarey M, Goldblatt D, Greenwood B, Griffiths U, Hajjeh R, Hassan-King M, Hugonnet S, Kimball AM, LaForce M, MacLennan C, Maiden MC, Manigart O, Mayer L, Messonnier N, Moisi J, Moore K, Moto DD, Mueller J, Nascimento M, Obaro S, Ouedraogo R, Page AL, Perea W, Pluschke G, Preziosi MP, Sow S, Stephens D, Stuart J, Thomson M, Tiendrebeogo S, Trape JF, Vernet G. Dakar discussion group on priorities for research on epidemic meningococcal disease in Africa, et al. Among authors: pluschke g. Vaccine. 2013 Mar 1;31(11):1453-7. doi: 10.1016/j.vaccine.2012.12.035. Epub 2012 Dec 27. Vaccine. 2013. PMID: 23273967 Free PMC article.
The global distribution and diversity of protein vaccine candidate antigens in the highly virulent Streptococcus pnuemoniae serotype 1.
Cornick JE, Tastan Bishop Ö, Yalcin F, Kiran AM, Kumwenda B, Chaguza C, Govindpershad S, Ousmane S, Senghore M, du Plessis M, Pluschke G, Ebruke C, McGee L, Sigaùque B, Collard JM, Bentley SD, Kadioglu A, Antonio M, von Gottberg A, French N, Klugman KP, Heyderman RS, Alderson M, Everett DB; PAGe consortium. Cornick JE, et al. Among authors: pluschke g. Vaccine. 2017 Feb 7;35(6):972-980. doi: 10.1016/j.vaccine.2016.12.037. Epub 2017 Jan 9. Vaccine. 2017. PMID: 28081968 Free PMC article.
262 results